New US risk class for embolisation devices
This article was originally published in Clinica
Executive Summary
The US FDA has announced its final rule downclassifying two embolisation device types from class III, which requires premarket approval, to a class II device, which requires only a 510(k), provided companies adhere to a new FDA guidance document on product submissions for these product types.